Alethia Young - Insider Trading & Ownership

Location
C/O Graphite Bio, Inc., 201 Haskins Way, Suite 210, South San Francisco, CA
Summary
The estimated net worth of Alethia Young is at least $2M dollars as of October 6, 2025. Alethia Young is the Director of PTC THERAPEUTICS, INC. and owns shares of PTC THERAPEUTICS, INC. (PTCT) stock worth about $1.01M. Alethia Young is the Director of Pacira BioSciences, Inc. and owns shares of Pacira BioSciences, Inc. (PCRX) stock worth about $610K. Alethia Young is the Chief Financial Officer of BICYCLE THERAPEUTICS PLC and owns shares of BICYCLE THERAPEUTICS PLC (BCYC) stock worth about $385K.
Signature
/s/ Travis Thompson, Attorney-in-Fact
All Insider Reports
All Insider Reports

Ownership of Alethia Young

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
PTCT PTC THERAPEUTICS, INC. Director $1.01M Jan 3, 2025
PCRX Pacira BioSciences, Inc. Director $610K Jun 11, 2025
BCYC BICYCLE THERAPEUTICS PLC Chief Financial Officer $385K -$26.9K -6.54% Oct 2, 2025
LENZ LENZ Therapeutics, Inc. Chief Financial Officer Feb 21, 2023

Insider Transactions Reported by Alethia Young:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.